Target intelligence / Profile preview

RNA, U6 small nuclear 31, pseudogene (RNU6-31P)

Target
RNU6-31P
Molecular classification
Other (Pseudogene; derived from snRNA gene)[1][3]
01

Overview

RNU6-31P is a human pseudogene—an inactive gene copy—derived from the functional U6 small nuclear RNA gene. The U6 snRNA is a highly conserved, non-coding RNA that is an essential component of the spliceosome, responsible for catalyzing the excision of introns from pre-mRNA in eukaryotes[3][4][5]. U6 snRNA itself interacts with other spliceosomal snRNAs and proteins to assemble a functional RNA-protein complex; however, RNU6-31P does not produce functional RNA and is not involved in splicing or any other biological pathway[1][3]. No evidence supports molecular functions, biological processes, or disease associations for this pseudogene. Pseudogenes like RNU6-31P are prevalent in vertebrate genomes and reflect evolutionary conservation and gene duplication events, but they do not play functional roles.

Other names
RNU6-31PRNU6-31RNU6-6RNA, U6 small nuclear 6RNA, U6 small nuclear 31, pseudogene
02

Mechanism of action

None (not a drug target)

03

Biological functions

None (as a pseudogene, it does not have a direct biological function; the functional gene, U6 snRNA, is involved in splicing[3][4])
04

Disease associations

None established for this pseudogene
05

Safety considerations

None (not used or considered as a therapeutic target)
06

Interacting drugs

None (as a pseudogene, does not interact with drugs; no known therapeutically relevant interactions)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, U6 small nuclear 31, pseudogene (RNU6-31P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 31, pseudogene (RNU6-31P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call